June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

The United States has approved the world’s first twice-yearly HIV prevention shot, marking a major milestone in the ...

The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.

Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s ...

The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first ... of new infections are in women, who often need protection they can use without ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S ...